Press release
Investigation announced for Long-Term Investors in Hanmi Financial Corporation (NASDAQ: HAFC)
An investigation on behalf of investors in Hanmi Financial Corporation (NASDAQ: HAFC) shares over potential wrongdoing.
Investors who purchased shares of Hanmi Financial Corporation (NASDAQ: HAFC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Hanmi Financial directors breached their fiduciary duties and caused damage to the company and its shareholders.
On March 26, 2020, a lawsuit was filed against Hanmi Financial Corporation over alleged violations of Federal Securities Laws. The plaintiff alleged that, the defendants made false and/or misleading statements and/or failed to disclose that the specified $40.7 million troubled loan would necessitate further and future specific provisions for the Company - in the millions, that the specified $40.7 million troubled loan would necessitate the Company to appraise and take personal property securing a portion of the amount of the loan, and that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
On September 17, 2020, an amended Complaint was filed and on November 2, 2020, the Defendants filed a Motion to Dismiss the amended Complaint.
On March 17, 2021, the Court issued an Order granting Defendants' Motion to Dismiss but gave leave to amend the complaint.
On April 6, 2021, a second amended Complaint was filed and on May 21, 2021, the Defendants filed a Motion to Dismiss the second amended Complaint.
On August 15, 2022, the Court issued an Order denying Defendants' Motion to Dismiss.
Those who purchased shares of Hanmi Financial Corporation (NASDAQ: HAFC) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in Hanmi Financial Corporation (NASDAQ: HAFC) here
News-ID: 2850471 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Hanmi
Short Bowel Syndrome Market to Experience Notable Growth in Forecast Span by 203 …
The Key Short Bowel Syndrome Companie in the market inlcude - Zealand Pharma, Ironwood Pharmaceuticals, Hanmi Pharmaceutical, Shire, AbbVie, Hanmi Pharma, EMD Serono, Zealand Pharma, VectivBio AG, Baxter Healthcare, and others.
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain,…
Short Bowel Syndrome Market Growth Projections 2024-2034: DelveInsight Analysis …
The Key Short Bowel Syndrome Companies in the market include - Zealand Pharma, Ironwood Pharmaceuticals, Hanmi Pharmaceutical, Shire, AbbVie, Hanmi Pharma, EMD Serono, Zealand Pharma, VectivBio AG, Baxter Healthcare, and others.
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain,…
Short Bowel Syndrome Market to Show Remarkable Growth Trends from 2024 to 2034, …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Short Bowel Syndrome Market Report 2032: Epidemiology Data, Pipeline Therapies, …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Short Bowel Syndrome Market Report 2032: Epidemiology Data, Pipeline Therapies, …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Hanmi Financial Corporation (NASDAQ: HAFC) Investor Notice: Update in Lawsuit an …
The Shareholders Foundation announced an update in the lawsuit that was filed for certain investors in shares of Hanmi Financial Corporation (NASDAQ: HAFC)
If you purchased shares of Hanmi Financial Corporation (NASDAQ: HAFC), you have certain options should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On March 26, 2020, a lawsuit was filed against Hanmi Financial Corporation over alleged violations of Federal Securities Laws. The plaintiff…
